Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-21-069154

Director sold 145,637 shares at an average $32.26 ($4,698,091)

From the SEC's structured data for this filing

Trades in this filing

Lettmann Jason · Director

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2021-12-08 Sale : show line 1 in the form −35,836 $33.23 $1,190,830 2,232,251 I
2021-12-08 Sale : show line 2 in the form −4,883 $33.23 $162,262 304,339 I
2021-12-08 Sale : show line 3 in the form −1,531 $33.80 $51,748 2,230,720 I
2021-12-08 Sale : show line 4 in the form −208 $33.80 $7,030 304,131 I
2021-12-09 Sale : show line 5 in the form −11,452 $31.08 $355,928 2,219,268 I
2021-12-09 Sale : show line 6 in the form −1,560 $31.08 $48,485 302,571 I
2021-12-09 Sale : show line 7 in the form −42,203 $32.06 $1,353,028 2,177,065 I
2021-12-09 Sale : show line 8 in the form −5,751 $32.06 $184,377 296,820 I
Open-market sales · 145,637 sh · avg $32.26 · $4,698,091
Loading xslF345X03/doc4.xml…